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Abstract 
A 67-year-old man with a history of low anterior resection and diverting loop transverse 
colostomy for rectal carcinoma developed fulminant pseudomembranous colitis after 
stoma closure. Oral administration of vancomycin at 0.5 g every 6 h and colonoscopy 
with intracolic vancomycin administration was unsuccessful, but continuation of 
intracolic vancomycin with postural change resulted in dramatic recovery. Postural 
change may extend the efficacy of intracolic vancomycin, and intracolic vancomycin 
should be considered as an option between conventional therapy and surgical 
intervention for pseudomembranous colitis. 
 
Case Report 
The patient, a 67-year-old male with a previous medical history of hypertension and ossification of 
posterior longitudinal ligament of cervical spine, underwent low anterior resection with diverting loop 
transverse colostomy for rectal carcinoma at Tokyo Metropolitan Cancer and Infectious Diseases 
Center, Komagome Hospital in 2006. Since the anal margin was positive, postoperative radiotherapy 
was added (50 Gy per 25 fractions). Endoscopic dilation of anastomosis was performed, followed by 
stoma closure with resection and hand-sewn anastomosis 10 months after low anterior resection. At 
laparotomy, cefmetazole 2 g was administered. The patient’s recovery was uneventful until 
postoperative day 8 when he developed high fever (38.8°C), mild hypoxia and distension without  
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diarrhea. White blood cell (WBC) count was 18,300 cells/mm
3 and C-reactive protein (CRP) was 
12.8 mg/dl. Administration of oxygen and parenteral cephoperazon/sulbactam (CPZ/SBT) 0.5 g twice 
daily were started empirically. On postoperative day 9, computed tomography of the abdomen showed 
the dilated (up to 59 mm) colon with thickened (up to 3 mm) wall. Colonoscopy showed no stricture of 
anastomoses, but revealed aperistalsis and diffuse pseudomembranes (fig. 1a), which resulted positive 
for Clostridium difficile toxin A by immunochromatography assay (UNIQUICK, Kanto Chemical Co., 
Inc., Tokyo, Japan).  
The CPZ/SBT was discontinued and a course of oral vancomycin 500 mg and live probiotic 
Bifidobacterium 1 g respectively four times daily were started for fulminant pseudomembranous colitis 
(PMC). Though flatus and defecation were seen, distention exacerbated on the fifth day of therapy. 
Colonoscopy revealed exacerbation of PMC (fig. 1b), and a soft 22-French catheter was placed in the 
colon. The tip was positioned in the transverse colon. During the colonoscopy, decompression and 
vancomycin 500 mg was administered directly into the colon. It was followed with intracolic 
administration of vancomycin 500 mg with live probiotic Bifidobacterium 1 g in 500 ml water every six 
hours. The retention time of enema was one hour. A 12-French transnasal ileus tube was also placed. 
On the 20th day of the therapy (15 days after the initiation of intracolic vancomycin), he had high fever 
(39.5°C), though exacerbation of inflammation was not evident (WBC 5,700 cells/mm
3, CRP 9.6 mg/dl), 
and a third colonoscopy was performed. It showed partial improvement and partial exacerbation of 
PMC. In the improved portion, edematous regenerative mucosa was seen, and the location included 
ventral cecum and transverse colon (fig. 2a). In the exacerbated portion, some ulcers with exposed 
muscularis propria were seen with coagula, and the location was limited to the dorsal cecum and hepatic 
flexure (fig. 2b). It seemed to implicate that the dorsal mucosa was severely damaged and that there was 
ventral improvement, so we changed the pattern of drug delivery, changing the patient’s position every 
15 min (spine, right decubitus, prone, left decubitus) in order that the intestinal fluid and the medicine 
were mixed without staying at the same place, which resulted in gradual clinical improvement. A fourth 
colonoscopy was performed after 13 days of the new pattern of intracolic vancomycin administration, 
and it showed complete resolution of the colitis without detectable pseudomembranes, though some 
ulcer scars were seen (fig. 3). The ileus tubes were removed 30 days after the initiation of vancomycin. 
The patient suffered stricture of esophagogastric junction, which was resolved by endoscopic dilation, 
and has been symptom-free so far. 
Discussion 
Closure of temporary stoma is known to have a set of potential surgical complication, 
such as leak, wound infection, stricture, obstruction and hernias [1], but C. difficile 
fulminant colitis after closure of temporary stoma has never been reported. Radiotherapy 
has been reported to have a chance to increase C. difficile, in the setting of patients with 
uterine carcinoma who underwent postoperative radiation therapy [2], but this patient 
was free of symptom during and after radiotherapy. 
The clinical picture of a C. difficile infection varies from an asymptomatic carrier to 
fulminant colitis with toxic megacolon. Age over 65 year, previous antibiotic use, 
immunosuppression, acid suppression, and operation are reported to increase the 
incidence of C. difficile-associated disease (CDAD) [3, 4], and a WBC count >16,000 
cells/mm
3 at initiation of therapy, operative therapy within the last 30 days, a history of 
inflammatory bowel disease, and a history of intravenous immunoglobulin treatment are 
risk factors for the development of fulminant C. difficile colitis [5]. 
Treatment of CDAD starts with discontinuation of offending antibiotics and 
supportive therapy. For those who faile to respond within 2–3 days, the addition of 
metronidazole is recommended, and vancomycin given orally is reserved for patients who 
fail to respond to metronidazole, whose organism is resistant to metronidazole, who are 
unable to tolerate metronidazole, who are pregnant, who are children under the age of 10, 
or who are critically ill [6]. Since our patient was critically ill, we adopted vancomycin.  
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Surgical intervention is considered an option for CDAD patients with toxic dilatation 
of the colon, bowel perforation, systemic toxicity, and failure to respond to medical 
treatment, but postoperative mortality is as high as 40% [3]. Since the patient was 
critically ill but vitally stable, we decided to continue medical treatment. Intravenous 
metronidazole can be an option for critically ill patients who are unable to take oral 
antimicrobial agents [7], but its efficacy is controversial [8] and it is not available in Japan. 
So we selected another option, intracolic vancomycin therapy [9]. The reported regimen 
varies (dose 1–3 g/day, interval 4–12 h), and the concerns about the potential efficacy of 
delivery of intracolic vancomycin to the transverse and right colon has been discussed 
[9, 10], and it has never been directly shown by colonoscopic imaging before. 
This case is unique in that the delivery of intracolic vancomycin was achieved by 
transanal ileus tube with postural change, and in that the time course of exacerbation 
from left-side colitis to diffuse colitis and its recovery was recorded with frequent 
colonoscopic studies. It is notable that vancomycin reached the cecum through the 
transanal ileus tube, which was indicated by the improvement of dorsal cecum shown by 
the 3rd colonoscopy. It is also notable that the findings indicate that the right colon, 
especially the dorsal end, can be the critical portion for treatment failure. This may be 
related to the obligate anaerobic nature of C. difficile [11] and the postural change may 
help increase the exposure of oxygen to C. difficile that hide beneath the intestinal fluid. 
Though the time course was longer than in other reported cases (2–14 days) [9], this 
patient was barely controlled. The frequent decompression and survey by colonoscopy, 
followed by continuous decompression and intracolic administration of vancomycin 
through the transanal long tube with postural change, should be considered an option 
between conventional therapy and surgical intervention for PMC. 
 
 
 
 
 
Fig. 1. Colonoscopy performed on postoperative day 9 revealed diffuse areas of pseudomembranes 
throughout the remaining colon (a), and colonoscopy performed after 5 days of oral vancomycin 
revealed exacerbation of colitis (b). 
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Fig. 2. Colonoscopy performed 15 days after the second colonoscopy, during which intracolic and 
transnasal vancomycin was administered, revealed the mixture of exacerbation and improvement. The 
cecum consisted of an exacerbated dorsal portion and an improved ventral portion (a), and 
exacerbation was severe especially around the hepatic flexure (b). In the improved portion, mucosa was 
very edematous, and in the exacerbated portion, some ulcers with exposed muscularis propria were seen 
with coagula. 
 
 
 
Fig. 3. Colonoscopy performed 13 days after the third colonoscopy, during which postural change 
during intracolic vancomycin administration was performed, showed complete resolution of the colitis 
without detectable pseudomembranes (a), though some ulcer scars were seen in the dorsal cecum and 
the hepatic flexure (b). 
 
  
Case Rep Gastroenterol 2010;4:133–137 
DOI: 10.1159/000314198 
Published online: May 12, 2010  © 2010 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
137
References 
1  Shellito PC: Complications of abdominal stoma surgery. Dis Colon Rectum 
1998;41:1562–1572. 
2  Cuzzolin L, Zambreri D, Donini M, Griso C, Benoni G: Influence of radiotherapy 
on intestinal microflora in cancer patients. J Chemother 1992;4:176–179. 
3  Monaghan T, Boswell T, Mahida YR: Recent advances in Clostridium difficile-
associated disease. Gut 2008;57:850–860. 
4  Cleary RK: Clostridium difficile-associated diarrhea and colitis: clinical 
manifestations, diagnosis, and treatment. Dis Colon Rectum 1998;41:1435–1449. 
5  Greenstein AJ, Byrn JC, Zhang LP, Swedish KA, Jahn AE, Divino CM: Risk 
factors for the development of fulminant Clostridium difficile colitis. Surgery 
2008;143:623–629. 
6  Fekety R: Guidelines for the diagnosis and management of Clostridium difficile-
associated diarrhea and colitis. American College of Gastroenterology, Practice 
Parameters Committee. Am J Gastroenterol 1997;92:739–750. 
7  Friedenberg F, Fernandez A, Kaul V, Niami P, Levine GM: Intravenous 
metronidazole for the treatment of Clostridium difficile colitis. Dis Colon Rectum 
2001;44:1176–1180. 
8  Guzman R, Kirkpatrik J, Forward K, Lim F: Failure of parenteral metronidazole in 
the treatment of pseudomembranous colitis [letter]. J Infect Dis 1988;158:1146–
1147. 
9  Apisarnthanarak A, Razavi B, Mundy LM: Adjunctive intracolic vancomycin for 
severe Clostridium difficile colitis: case series and review of the literature. Clin 
Infect Dis 2002;35:690–696. 
10  Pasic M, Jost R, Carrel T, Von Segesser L, Turina M: Intracolic vancomycin for 
pseudomembranous colitis. N Engl J Med 1993;329:583. 
11  Hall IC, O’Toole E: Intestinal flora in new-born infants with a description of a 
new pathogenic anaerobe: Bacillus difficilis. Am J Dis Child 1935;48:390–402. 
 